Tag: 2021 National Synthetic Biology Roadmap
Synthetic biology advancements propose $30B opportunity for Australia
A collaborative effort between CSIRO and Main Sequence Ventures has unveiled Australia's strides in adhering to ten recommendations outlined in the National Synthetic Biology Roadmap, indicating significant progress towards a potentially lucrative industry.
Featured Article
Why energy is becoming a strategic asset for manufacturers
Energy is no longer just a cost centre for manufacturers – it is fast becoming a strategic lever for efficiency, resilience and growth.
